These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 15745346

  • 1. [The 10-minute consultation. Accidental finding: hyperkalemia. Caution with analgesics and bananas].
    Lenz T.
    MMW Fortschr Med; 2005 Jan 27; 147(4):59-60. PubMed ID: 15745346
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].
    Dutka M, Dzielski T, Wojciechowska J, Heller L, Trybus M.
    Pol Merkur Lekarski; 1999 Aug 27; 7(38):69-70. PubMed ID: 10522422
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 27; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Life-threatening hyperkalaemia caused by ACE inhibitor and diuretics.
    Jarman PR, Keheley AM, Mather HM.
    Diabet Med; 1997 Sep 27; 14(9):808. PubMed ID: 9300234
    [No Abstract] [Full Text] [Related]

  • 10. Life-threatening hyperkalaemia caused by angiotensin-converting enzyme-inhibitor and diuretics.
    Odawara M, Asano M, Yamashita K.
    Diabet Med; 1997 Feb 27; 14(2):169-70. PubMed ID: 9047098
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
    Thomason JD, Rockwell JE, Fallaw TK, Calvert CA.
    J Vet Cardiol; 2007 Nov 27; 9(2):103-8. PubMed ID: 17983885
    [Abstract] [Full Text] [Related]

  • 13. Spironolactone in patients with heart failure.
    Vanpee D, Swine C.
    N Engl J Med; 2000 Jan 13; 342(2):133; author reply 133-4. PubMed ID: 10636753
    [No Abstract] [Full Text] [Related]

  • 14. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases.
    Schepkens H, Vanholder R, Billiouw JM, Lameire N.
    Am J Med; 2001 Apr 15; 110(6):438-41. PubMed ID: 11331054
    [Abstract] [Full Text] [Related]

  • 15. [Hypertension and diabetic nephropathy, a dangerous duo].
    Hausberg M, Hohage H, Kosch M.
    Med Klin (Munich); 2005 Nov 15; 100(11):729-37; quiz 738-9. PubMed ID: 16328181
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.
    Prescrire Int; 2004 Apr 15; 13(70):58. PubMed ID: 15148978
    [No Abstract] [Full Text] [Related]

  • 18. [A patient with severe hyperkalaemia -- an emergency after RALES].
    Nürnberger J, Daul A, Philipp T.
    Dtsch Med Wochenschr; 2005 Sep 09; 130(36):2008-11. PubMed ID: 16143930
    [Abstract] [Full Text] [Related]

  • 19. Drug safety in patients with heart failure.
    Juurlink DN, Hansten PD.
    Arch Intern Med; 2005 Jan 10; 165(1):118. PubMed ID: 15642888
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.